These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17352347)

  • 1. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.
    Cho JW; Kim SY; Park SS; Kim HJ; Ahn TB; Kim JM; Jeon BS
    Can J Neurol Sci; 2007 Feb; 34(1):53-5. PubMed ID: 17352347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the G2019S LRRK2 mutation common in all southern European populations?
    Papapetropoulos S; Adi N; Shehadeh L; Bishopric N; Singer C; Argyriou AA; Chroni E
    J Clin Neurosci; 2008 Sep; 15(9):1027-30. PubMed ID: 18617409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
    Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
    Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
    Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
    Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 and Parkinson's disease in Norway.
    Toft M; Haugarvoll K; Ross OA; Farrer MJ; Aasly JO
    Acta Neurol Scand Suppl; 2007; 187():72-5. PubMed ID: 17419834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.
    Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N
    J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
    Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
    Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
    Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
    Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
    Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy.
    De Rosa A; Criscuolo C; Mancini P; De Martino M; Giordano IA; Pappatà S; Filla A; De Michele G
    Parkinsonism Relat Disord; 2009 Mar; 15(3):242-4. PubMed ID: 18621566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
    Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
    Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.
    Tan EK; Shen H; Tan LC; Farrer M; Yew K; Chua E; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yih Y; Skipper L; Liu JJ
    Neurosci Lett; 2005 Aug; 384(3):327-9. PubMed ID: 15955629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
    Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
    J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.
    Hashad DI; Abou-Zeid AA; Achmawy GA; Allah HM; Saad MA
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):861-6. PubMed ID: 21699405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.